Dohyun Son

Biochemistry, Genetics and Molecular Biology · Life Sciences

8h-index236citations9works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Advanced Glycation End Products research(3), Alzheimer's disease research and treatments(2), Natural Antidiabetic Agents Studies(2), TGF-β signaling in diseases(2), Histone Deacetylase Inhibitors Research(2)

Publications9 total

390 IL-7 and CCL19 expressing iPSC-derived NK cells to harness the adaptive immunity against solid tumors
Regular and Young Investigator Award Abstracts·2024Open Access
SAR Studies of Indole-5-propanoic Acid Derivatives To Develop Novel GPR40 Agonists
ACS Medicinal Chemistry Letters·2017· 9 citedOpen Access
Computer-aided identification of new histone deacetylase 6 selective inhibitor with anti-sepsis activity
European Journal of Medicinal Chemistry·2016· 18 citedOpen Access
Identification of new quinic acid derivatives as histone deacetylase inhibitors by fluorescence-based cellular assay
Bioorganic & Medicinal Chemistry Letters·2016· 11 citedOpen Access
Fine tuning of 4,6-bisphenyl-2-(3-alkoxyanilino)pyrimidine focusing on the activity-sensitive aminoalkoxy moiety for a therapeutically useful inhibitor of receptor for advanced glycation end products (RAGE)
Bioorganic & Medicinal Chemistry·2014· 14 cited
Pyrazole-5-carboxamides, novel inhibitors of receptor for advanced glycation end products (RAGE)
European Journal of Medicinal Chemistry·2014· 64 citedOpen Access
Synthesis and biological evaluation of 2-benzylamino-4(5)-(6-methylpyridin-2-yl)-5(4)-([1,2,4]triazolo[1,5-a]-pyridin-6-yl)thiazoles as transforming growth factor-β type 1 receptor kinase inhibitors
European Journal of Medicinal Chemistry·2012· 27 citedOpen Access
Ligand-Based Design, Synthesis, and Biological Evaluation of 2-Aminopyrimidines, a Novel Series of Receptor for Advanced Glycation End Products (RAGE) Inhibitors
Journal of Medicinal Chemistry·2012· 58 citedOpen Access
Synthesis and biological evaluation of 1-substituted-3(5)-(6-methylpyridin-2-yl)-4-(quinoxalin-6-yl)pyrazoles as transforming growth factor-β type 1 receptor kinase inhibitors
European Journal of Medicinal Chemistry·2011· 35 citedOpen Access

Frequent Co-authors

Hyun‐Ju Park(8), Young Taek Han(3), Jeewoo Lee(3), Young‐Ger Suh(3), Kyeojin Kim(2), Gyeong-In Choi(2), Hongchan An(2), Hee-Jin Ha(2), Hee Yeon Kim(2), Cheng Hua Jin(2), D. Sreenu(2), Maddeboina Krishnaiah(2), Vura Bala Subrahmanyam(2), Kota Sudhakar Rao(2), Yhun Yhong Sheen(2), Dae‐Kee Kim(2), Hee Kim(1), Jun-Hyeng Son(1), Suk‐Jae Chung(1), Nam‐Jung Kim(1)